Prostate cancers are either low-grade, low-risk forms that may be monitored but otherwise untreated, or they’re serious enough to require surgery and radiation. Monitoring can cause patients anxiety.
NEW YORK--(BUSINESS WIRE)-- The premier authority in the use of advanced imaging to diagnose prostate tumors and the utilization of MRI-guided transrectal focal laser ablation for treating these ...
IRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the first patient has been safely treated in its recently ...
IRVINE, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the clinical study performed in collaboration with Toronto General Hospital, Canada, ...
IRVINE, Calif. and MIAMI, Jan. 31, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced the full twenty ...
IRVINE, Calif. and SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) -- A correction has been issued for a release issued under the same headline earlier today by Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, Jan. 31, 2023 (GLOBE NEWSWIRE) -- CLS Americas, a leading provider of office-based, focal laser ablation systems in the US urology market, today announced the full twenty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback